CDXS
CODEXIS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.36
+3.03%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.09
- Revenue estimate
- $18.3M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.14
- Revenue actual
- $14.9M
- Revenue estimate
- $14.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +105.7%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $8.00
- PT range
- $8.00 – $8.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.14 | -$0.13 | Beat 8.24% | $14.9M |
| May 7, 2026 | -$0.11 | -$0.10 | Beat 9.09% | $15.2M |
| Mar 11, 2026 | -$0.03 | $0.11 | Beat 452.00% | $38.9M |
| Nov 6, 2025 | -$0.15 | -$0.22 | Miss -46.67% | $8.6M |
| Aug 13, 2025 | -$0.17 | -$0.16 | Beat 5.88% | $15.3M |
| May 14, 2025 | -$0.20 | -$0.25 | Miss -25.00% | $7.5M |
| Feb 27, 2025 | -$0.04 | -$0.13 | Miss -225.00% | $21.5M |
| Oct 31, 2024 | -$0.25 | -$0.29 | Miss -16.00% | $12.8M |
| Aug 8, 2024 | -$0.26 | -$0.32 | Miss -23.08% | $8.0M |
| May 2, 2024 | -$0.17 | -$0.16 | Beat 5.88% | $17.1M |
| Feb 28, 2024 | -$0.16 | $0.02 | Beat 112.50% | $26.6M |
| Nov 2, 2023 | -$0.32 | -$0.26 | Beat 18.75% | $9.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026